Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/95471

Beta release

Statistics of The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0900
2024-1000